All studies included patients with histologically diagnosed “glioblastomas, isocitrate dehydrogenase (IDH)-wild type” or “astrocytoma, IDH-mutant, grade 4” who had undergone standard of care treatment.6,34. Here, IDH3A is linked to astrocytoma (excluding glioblastoma).